Migration deficit in monocyte-macrophages in human ovarian cancer

Cancer Immunology, Immunotherapy

Volumn 57, Issue 5, 2008, Pages 635-645

  Freedman, Ralph S ^a   Ma, Qing ^a   Wang, Ena ^b   Gallardo, Stacie T ^a   Gordon, Ilyssa O ^a   Shin, Jeong Won ^b   Jin, Ping ^b   Stroncek, David ^b   Marincola, Francesco M ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; F ACTIN;

ACTIN POLYMERIZATION; ARTICLE; CANCER PATIENT; CELL MIGRATION; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSKELETON; DEPOLYMERIZATION; DNA MICROARRAY; DOWN REGULATION; FOCAL ADHESION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MACROPHAGE; MONOCYTE; OVARY CANCER; PRIORITY JOURNAL;

ACTINS; CELL MOVEMENT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MONOCYTES; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; RECEPTORS, CCR1; RECEPTORS, CCR5; RECEPTORS, CXCR4;

EID: 43149108380     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0401-5     Document Type: Article

References (32)

1. Piccart M, Bertelsen K, Stuart G, Cassidy J, Mangioni C, Simonsen E, James K, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson R, Swenerton K, Trope C, Nardi M, Kaern J, Tumolo S, Timmers P, Roy J-A, Lhoas F, Lidvall B, Bacon M, Birt A, Andersen J, Zee B, Paul J, Pecorelli S, Baron B, McGuire W (2003) Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer 13(Suppl 2):144-148
2. Wang X, Deavers M, Patenia R, Bassett RL, Mueller P, Ma Q, Wang E, Freedman RS (2006) Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease. J Trans Med 4:30
3. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549-555
4. Balkwill F, Ward B, Moodie E (1987) Therapeutic potential of tumor necrosis factor-α and r-interferon in experimental human ovarian cancer. Cancer Res 47:4755-4758
5. Colombo MP, Mantovani A (2005) Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion. Cancer Res 65(20):9113-9116
6. Balkwill FR, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539-545
7. Chambers S, Kacinski B, Ivins C, Carcangiu M (1997) Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 3:999-1007
8. Kacinski B (1995) CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 27:79-85
9. Xu FJ, Ramakrishnan S, Daly L, Soper JT, Berchuck A, Clarke-Pearson D, Bast RCJ (1991) Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. Am J Obstet Gynecol 165:1356-1362
10. Price F, Chambers S, Chambers J, Carcangiu M, Schwartz P, Kohorn E, Stanley E, Kacinski B (1993) Colony-stimulating factor-1 in primary ascites in ovarian cancer is a significant predictor of survival. Am J Obstet Gynecol 168:520-527
11. Kassim SK, El-Salahy EM, Fayed ST, Helal SA, Helal T, Azzam E-D, Khalifa A (2004) Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem 37(5):363-369
12. Loercher AE, Nash MA, Kavanagh JJ, Platsoucas CD, Freedman RS (1999) Identification of an IL-10 producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol 163:6251-6260
13. Gordon IO, Freedman RS (2006) Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients. Clin Cancer Res 12(5):1515-1524
14. Wang E, Ngalame Y, Panelli MC, Nguyen-Jackson H, Deavers M, Mueller P, Hu W, Savary C, Kobayashi R, Freedman RS, Marincola FM (2005) Peritoneal and sub-peritoneal stroma may facilitate regional spread of ovarian cancer. Clin Cancer Res 11(1):113-122
15. Melchers F, Rolink A, Schaniel C (1999) The role of chemokines in regulating cell migration during humoral immune responses. Cell 99:351-354
16. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-127
17. Mackay C (2001) Chemokines: immunology's high impact factors. Nat Immunol 2:95-101
18. Ma Q, Jones D, Springer T (1999) The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10(4):463-471
19. Schutyser E, Struyf S, Proost P, Opdenakker G, Laureys G, Verhasselt B, Peperstraete L, Van de Putte I, Saccani A, Allavena P, Mantovani A, Van Damme J (2002) Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem 277(27):24584-24593
20. Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill FR (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95(5):2391-2396
21. Freedman RS, Tomasovic B, Templin S, Atkinson EN, Kudelka A, Edwards CL, Platsoucas CD (1994) Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Meth 167:145-160
22. Tukey JW (1951) Reminder sheets for "Discussion of paper on multiple comparisons by Henry Scheffe." In: The collected works of John W Tukey VIII: multiple comparisons: 1948-1983ed. Chapman Hall, London pp 469-475
23. Kim CH, Broxmeyer HE (1998) In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91(1):100-110
24. Wang E (2005) RNA amplification for successful gene profiling analysis. J Trans Med 3:28
25. Wang E, Miller L, Ohnmacht GA, Liu E, Marincola FM (2000) High fidelity mRNA amplification for gene profiling. Nat Biotechnol 18:457-459
26. Imai T, Horiuchi A, Shiozawa T, Osada R, Kikuchi N, Ohira S, Oka K, Konishi I (2004) Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum Pathol 35(12):1469-1476
27. Scotton CJ, Milliken D, Wilson J, Raju S, Balkwill FR (2001) Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br J Cancer 85(6):891-897
28. Freedman RS, Wang E, Voiculescu S, Patenia R, Bassett RL, Deavers M, Marincola FM, Yang P, Newman RA (2007) Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer. Clin Cancer Res 13(19):5736-5744
29. Giannone G, Dubin-Thaler BJ, Rossier O, Cai Y, Chaga O, Jiang G, Beaver W, Dobereiner HG, Freund Y, Borisy G, Sheetz MP (2007) Lamellipodial actin mechanically links myosin activity with adhesion-site formation. Cell 128(3):561-575
30. Schaub S, Meister JJ, Verkhovsky AB (2007) Analysis of actin filament network organization in lamellipodia by comparing experimental and simulated images. J Cell Sci 120(Pt 8):1491-1500
31. Sessa C, De Braud F, Perotti A, Bauer J, Curigliano G, Noberasco C, Zanaboni F, Gianni L, Marsoni S, Jimeno J, D'Incalci M, Dall'o E, Colombo N (2005) Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails. J Clin Oncol 23(9):1867-1874
32. Nimmerjahn F, Ravetch JV (2005) Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 310:1510-1512